Disability progression in relapsing MS tends to follow one of four distinct patterns, according to a new study.

A single dose of Immutep’s MS therapy, IMP761, was well tolerated and reduced T-cell activity for up to 23 days in healthy ...

People with higher blood levels of certain manufactured compounds that persist in the environment are more likely to be ...

Fear of relapse and progression is common in multiple sclerosis patients. This fear causes anxiety, depression, fatigue, and lower quality of life. Support, education, coping strategies, and screening ...

MS relapses are more common in spring and summer, coinciding with warmer, drier weather and atmospheric changes, a study ...

As multiple sclerosis (MS) progresses, some people transition to secondary progressive multiple sclerosis (SPMS) — a stage of MS in which symptoms gradually worsen over time, often with fewer relapses ...

The CEMIP enzyme inhibits the growth of oligodendrocytes and may serve as a therapeutic target to boost myelin repair in MS, ...

Columnist Ben Hofmeister never feels he's quite ready for the unpredictability of MS, which makes planning for life's challenges hard.

Taking lipoic acid failed to ease progressive MS symptoms in a clinical trial, but the antioxidant showed signs of slowing ...

Myelin loss disrupts the coordination of signals between brain regions, impairing the accurate processing of information, researchers found.

A clinical trial testing whether music therapy can make botulinum toxin injections for spasticity more comfortable is ...